Main Article Content
Background. Currently, there is no specialized structured program in the world for group training of patients with type 1 diabetes mellitus receiving insulin pump therapy. The purpose of this work was to evaluate the effectiveness of a modified training program in achieving target glycemic levels in children and adolescents with type 1 diabetes mellitus on insulin pump therapy. Material and methods. The training was carried out at the “School of type 1 diabetes mellitus” at the Children’s Clinical Hospital No. 2 in Almaty on an outpatient basis for five days. During the training, a modified program was used, which included all training sections. The survey enrolled 125 children and adolescents with type 1 diabetes mellitus, 68 of them were included in the group of a modified educational program, who studied annually at the “School of type 1 diabetes mellitus”. The group without training (controls) consisted of 57 children and adolescents with type 1 diabetes mellitus, who were trained at the “School of type 1 diabetes mellitus” by the traditional method. All subjects were tested on the basis of a questionnaire, which included 30 key questions on self-control of insulin pump therapy and bread units before and after training. Results. Sixty-eight patients with a modified training program were divided into two subgroups depending on the method of assessing glycemia. The compensation was evaluated by determining the level of glycated hemoglobin (HbA1c). Target therapy levels were better in the modified learning groups than in the control group, which confirms the greater role of motivated parents in the control of type 1 diabetes mellitus, with frequent blood glucose measurements on FreeStyle Libre sensors. Conclusions. The creation of a modified structured training program for patients with type 1 diabetes mellitus, taking into account individual characteristics, as well as cultural and national traditions, is relevant and timely.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr. 2019 Aug;32(3):194-204. doi:10.2337/ds18-0091.
Mameli C, Scaramuzza AE, Ho J, et al. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. Acta Diabetol. 2014 Apr;51(2):205-10. doi:10.1007/s00592-013-0481-y.
Brorsson AL, Viklund G, Örtqvist E, Lindholm Olinder A. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study. Pediatr Diabetes. 2015 Nov;16(7):546-53. doi:10.1111/pedi.12209.
Forlenza GP, Buckingham B, Maahs DM. Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. J Pediatr. 2016 Feb;169:13-20. doi:10.1016/j.jpeds.2015.10.015.
Ly TT, Layne JE, Huyett LM, Nazzaro D, O'Connor JB. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age. J Diabetes Sci Technol. 2019 Jan;13(1):20-26. doi:10.1177/1932296818798836.
Vigersky RA, Huang S, Cordero TL, et al; OpT2mise Study Group. Improved Hba1c, Total Daily Insulin Dose, And Treatment Satisfaction With Insulin Pump Therapy Compared To Multiple Daily Insulin Injections In Patients With Type 2 Diabetes Irrespective Of Baseline C-Peptide Levels. Endocr Pract. 2018 May;24(5):446-452. doi:10.4158/EP-2017-0234.
Muratalina A, Smith-Palmer J, Nurbekova A, et al. Project Baiterek: A Patient Access Program to Improve Clinical Outcomes and Quality of Life in Children with Type 1 Diabetes in Kazakhstan. Value Health Reg Issues. 2015 Sep;7:74-79. doi:10.1016/j.vhri.2015.09.002.
Supiyev A, Kossumov A, Kassenova A, et al. Diabetes prevalence, awareness and treatment and their correlates in older persons in urban and rural population in the Astana region, Kazakhstan. Diabetes Res Clin Pract. 2016 Feb;112:6-12. doi:10.1016/j.diabres.2015.11.011.
Rytter K, Schmidt S, Rasmussen LN, Pedersen-Bjergaard U, Nørgaard K. Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review. Diabetes Metab Res Rev. 2020 Oct 3:e3412. doi:10.1002/dmrr.3412.
Marks BE, Wolfsdorf JI, Waldman G, Stafford DE, Garvey KC. Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose Monitors. Diabetes Technol Ther. 2019 Mar;21(3):105-109. doi:10.1089/dia.2018.0331.
AbdulAziz YH, Al-Sallami HS, Wiltshire E, et al; Paediatric Society of New Zealand Diabetes Clinical Network. Insulin pump initiation and education for children and adolescents - a qualitative study of current practice in New Zealand. J Diabetes Metab Disord. 2019 Feb 12;18(1):59-64. doi:10.1007/s40200-019-00390-6.
Bergis D, Ehrmann D, Albrecht C, Haak T, Kulzer B, Hermanns N. Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a randomized controlled trial setting and the effectiveness in a routine care setting: Results of a comparative effectiveness study. Patient Educ Couns. 2019 Oct;102(10):1868-1874. doi:10.1016/j.pec.2019.04.021.
Quirós C, Jansà M, Viñals C, et al. Experiences and real life management of insulin pump therapy in adults with type 1 diabetes. Endocrinol Diabetes Nutr (Engl Ed). 2019 Feb;66(2):117-123. doi:10.1016/j.endinu.2018.05.017. (in Spanish).
Rilstone S, Reddy M, Oliver N. Glycemic Index, Extended Bolusing, and Diabetes Education in Insulin Pump Therapy (GLIDE: A Pilot Study). Diabetes Technol Ther. 2019 Aug;21(8):452-455. doi:10.1089/dia.2019.0079.
De Valk HW, Lablanche S, Bosi E, et al. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes. Diabetes Technol Ther. 2018 Nov;20(11):758-766. doi:10.1089/dia.2018.0222.
O'Connell MA, Gilbertson HR, Donath SM, Cameron FJ. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type. Diabetes Care. 2008 Aug;31(8):1491-5. doi:10.2337/dc08-0306.
Deeb A, Qahtani NA, Ali AA, Akle M. Impact of targeted education on managing warning and error signals by children and adolescents with type 1 diabetes using the Accu-Chek Combo Insulin Pump System. Ann Pediatr Endocrinol Metab. 2017 Sep;22(3):170-175. doi:10.6065/apem.2017.22.3.170.
Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015 Apr;38(4):716-22. doi:10.2337/dc15-0168.